Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway

Journal of Cystic Fibrosis

Volumn 9, Issue 2, 2010, Pages 84-92

  Chapman, Anna L P ^a   Morrissey, Brian M ^a   Vasu, Vihas T ^a   Juarez, Maya M ^a   Houghton, Jessica S ^a   Li, Chin Shang ^a   Cross, Carroll E ^a   Eiserich, Jason P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Expired nitric oxide; Myeloperoxidase; Neutrophils; Oxidants; Oxidative stress; Sputum

Indexed keywords

HEMOPROTEIN; HYDROGEN PEROXIDE; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXIDASE; REACTIVE OXYGEN METABOLITE;

ADULT; AEROBIC METABOLISM; AIRWAY; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; ENZYME ACTIVITY; EXPIRED AIR; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; METABOLITE; PHAGOCYTE; PNEUMONIA; PSEUDOMONAS; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; SPUTUM EXAMINATION;

ADULT; BIOLOGICAL AVAILABILITY; BREATH TESTS; CYSTIC FIBROSIS; EXHALATION; FEMALE; HUMANS; HYDROGEN PEROXIDE; MALE; NITRATES; NITRIC OXIDE; NITRITES; OXIDATION-REDUCTION; PEROXIDASE; RESPIRATORY MUCOSA; RESPIRATORY SYSTEM; SPUTUM; YOUNG ADULT;

EID: 76749100658     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2009.10.001     Document Type: Article

References (48)

1. Kerem B., Rommens J.M., Buchanan J.A., Markiewicz D., Cox T.K., Chakravarti A., et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245 4922 (1989) 1073-1080
2. Boyle M.P. Strategies for identifying modifier genes in cystic fibrosis. Proc Am Thorac Soc 4 1 (2007) 52-57
3. Scheid P., Kempster L., Griesenbach U., Davies J.C., Dewar A., Weber P.P., et al. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J 17 1 (2001) 27-35
4. Carrabino S., Carpani D., Livraghi A., Di Cicco M., Costantini D., Copreni E., et al. Dysregulated interleukin-8 secretion and NF-kappaB activity in human cystic fibrosis nasal epithelial cells. J Cyst Fibros 5 2 (2006) 113-119
5. Moskwa P., Lorentzen D., Excoffon K.J., Zabner J., McCray Jr. P.B., Nauseef W.M., et al. A novel host defense system of airways is defective in cystic fibrosis. Am J Respir Crit Care Med 175 2 (2007) 174-183
6. Birrer P. Proteases and antiproteases in cystic fibrosis: pathogenetic considerations and therapeutic strategies. Respiration 62 Suppl 1 (1995) 25-28
7. Cantin A.M., White T.B., Cross C.E., Forman H.J., Sokol R.J., and Borowitz D. Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003. Free Radic Biol Med 42 1 (2007) 15-31
8. Kharitonov S.A., and Barnes P.J. Clinical aspects of exhaled nitric oxide. Eur Respir J 16 4 (2000) 781-792
9. Grasemann H., Michler E., Wallot M., and Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 24 3 (1997) 173-177
10. Lundberg J.O., Nordvall S.L., Weitzberg E., Kollberg H., and Alving K. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child 75 4 (1996) 323-326
11. Dotsch J., Demirakca S., Terbrack H.G., Huls G., Rascher W., and Kuhl P.G. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J 9 12 (1996) 2537-2540
12. Jones K.L., Hegab A.H., Hillman B.C., Simpson K.L., Jinkins P.A., Grisham M.B., et al. Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr Pulmonol 30 2 (2000) 79-85
13. Zetterquist W., Marteus H., Kalm-Stephens P., Nas E., Nordvall L., Johannesson M., et al. Oral bacteria - the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis. Respir Med 103 2 (2009) 187-193
14. Kelley T.J., and Drumm M.L. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 102 6 (1998) 1200-1207
15. Morrissey B.M., Schilling K., Weil J.V., Silkoff P.E., and Rodman D.M. Nitric oxide and protein nitration in the cystic fibrosis airway. Arch Biochem Biophys 406 1 (2002) 33-39
16. Fang F.C. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99 12 (1997) 2818-2825
17. Meng Q.H., Springall D.R., Bishop A.E., Morgan K., Evans T.J., Habib S., et al. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 184 3 (1998) 323-331
18. Grasemann H., Gaston B., Fang K., Paul K., and Ratjen F. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J Pediatr 135 6 (1999) 770-772
19. Snyder A.H., McPherson M.E., Hunt J.F., Johnson M., Stamler J.S., and Gaston B. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. Am J Respir Crit Care Med 165 7 (2002) 922-926
20. Fragoso M.A., Fernandez V., Forteza R., Randell S.H., Salathe M., and Conner G.E. Transcellular thiocyanate transport by human airway epithelia. J Physiol 561 Pt 1 (2004) 183-194
21. Mohammed J.R., Mohammed B.S., Pawluk L.J., Bucci D.M., Baker N.R., and Davis W.B. Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum. J Lab Clin Med 112 6 (1988) 711-720
22. Van Der Vliet A., Nguyen M.N., Shigenaga M.K., Eiserich J.P., Marelich G.P., and Cross C.E. Myeloperoxidase and protein oxidation in cystic fibrosis. Am J Physiol, Lung Cell Mol Physiol 279 3 (2000) L537-L546
23. Forteza R., Salathe M., Miot F., and Conner G.E. Regulated hydrogen peroxide production by Duox in human airway epithelial cells. Am J Respir Cell Mol Biol 32 5 (2005) 462-469
24. Babior B.M. NADPH oxidase: an update. Blood 93 5 (1999) 1464-1476
25. Kim J.S., Hackley G.H., Okamoto K., and Rubin B.K. Sputum processing for evaluation of inflammatory mediators. Pediatr Pulmonol 32 2 (2001) 152-158
26. Eiserich J.P., Baldus S., Brennan M.L., Ma W., Zhang C., Tousson A., et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296 5577 (2002) 2391-2394
27. Fahy J.V., Liu J., Wong H., and Boushey H.A. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol 93 6 (1994) 1031-1039
28. Society A.T., and Society E.R. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Cell Mol Biol 171 (2005) 912-930
29. Suresh V., Shelley D.A., Shin H.W., and George S.C. Effect of heterogeneous ventilation and nitric oxide production on exhaled nitric oxide profiles. J Appl Physiol 104 6 (2008) 1743-1752
30. Suri R., Paraskakis E., and Bush A. Alveolar, but not bronchial nitric oxide production is elevated in cystic fibrosis. Pediatr Pulmonol 42 12 (2007) 1215-1221
31. Hubert D., Aubourg F., Fauroux B., Trinquart L., Sermet I., Lenoir G., et al. Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments. Eur Respir J 34 1 (2009) 117-124
32. Zetterquist W., Pedroletti C., Lundberg J.O., and Alving K. Salivary contribution to exhaled nitric oxide. Eur Respir J 13 2 (1999) 327-333
33. Abu-Soud H.M., and Hazen S.L. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 275 48 (2000) 37524-37532
34. Gerson C., Sabater J., Scuri M., Torbati A., Coffey R., Abraham J.W., et al. The lactoperoxidase system functions in bacterial clearance of airways. Am J Respir Cell Mol Biol 22 6 (2000) 665-671
35. Abu-Soud H.M., and Hazen S.L. Nitric oxide modulates the catalytic activity of myeloperoxidase. J Biol Chem 275 8 (2000) 5425-5430
36. Thomas E.L., Jefferson M.M., Joyner R.E., Cook G.S., and King C.C. Leukocyte myeloperoxidase and salivary lactoperoxidase: identification and quantitation in human mixed saliva. J Dent Res 73 2 (1994) 544-555
37. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391 6665 (1998) 393-397
38. Linnane S.J., Keatings V.M., Costello C.M., Moynihan J.B., O'Connor C.M., Fitzgerald M.X., et al. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 158 1 (1998) 207-212
39. Wooldridge J.L., Deutsch G.H., Sontag M.K., Osberg I., Chase D.R., Silkoff P.E., et al. NO pathway in CF and non-CF children. Pediatr Pulmonol 37 4 (2004) 338-350
40. Yoon S.S., Coakley R., Lau G.W., Lymar S.V., Gaston B., Karabulut A.C., et al. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J Clin Invest 116 2 (2006) 436-446
41. Grasemann H., Kurtz F., and Ratjen F. Inhaled l-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis. Am J Respir Crit Care Med 174 2 (2006) 208-212
42. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., et al. Eosinophilic inflammation in asthma. N Engl J Med 323 15 (1990) 1033-1039
43. Konstan M.W., Hilliard K.A., Norvell T.M., and Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 150 2 (1994) 448-454
44. Danel C., Erzurum S.C., McElvaney N.G., and Crystal R.G. Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis. Am J Respir Crit Care Med 153 1 (1996) 362-368
45. Bove P.F., and van der Vliet A. Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radic Biol Med 41 4 (2006) 515-527
46. Fischer H., Schwarzer C., and Illek B. Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci U S A 101 10 (2004) 3691-3696
47. van Dalen C.J., Winterbourn C.C., Senthilmohan R., and Kettle A.J. Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation. J Biol Chem 275 16 (2000) 11638-11644
48. Turi J.L., Yang F., Garrick M.D., Piantadosi C.A., and Ghio A.J. The iron cycle and oxidative stress in the lung. Free Radic Biol Med 36 7 (2004) 850-857